|
Name |
Tryptophol
|
Molecular Formula | C10H11NO | |
IUPAC Name* |
2-(1H-indol-3-yl)ethanol
|
|
SMILES |
C1=CC=C2C(=C1)C(=CN2)CCO
|
|
InChI |
InChI=1S/C10H11NO/c12-6-5-8-7-11-10-4-2-1-3-9(8)10/h1-4,7,11-12H,5-6H2
|
|
InChIKey |
MBBOMCVGYCRMEA-UHFFFAOYSA-N
|
|
Synonyms |
Tryptophol; 526-55-6; Indole-3-ethanol; 3-(2-Hydroxyethyl)indole; 1H-Indole-3-ethanol; 2-(1H-Indol-3-yl)ethanol; 3-Indoleethanol; 3-Indolylethanol; Indoleethanol; 2-(1h-indol-3-yl)ethan-1-ol; Indole ethanol; 2-(3-Indolyl)ethanol; Ethanol, 2-indol-3-yl-; ETHANOL, 3-INDOLYL-; 1H-Indolyl-3-ethanol; beta-Indol-3-ylethanol; 3-(beta-Hydroxyethyl)indole; 2-(1H-Indol-3-yl)-ethanol; NSC 3884; IEA; 2-(indol-3-yl)ethanol; Maybridge1_002422; .beta.-(3-Indole)ethanol; 3-(.beta.-Hydroxyethyl)indole; CHEBI:17890; 5809LZ7G1U; NSC-3884; MFCD00005659; EINECS 208-393-2; BRN 0125553; UNII-5809LZ7G1U; 3-indolethanol; Tryptaphol, 6; ZCW; (indol-3-yl)ethanol; 2-(3-Indolylethanol; b-(3-Indole)ethanol; TRYPTOPHOL [MI]; beta-(3-Indole)ethanol; 3-(b-Hydroxyethyl)indole; 2-(indol-3-yl)-ethanol; bmse000473; 3-(2-Hydroxyethyl) Indole; 5-21-03-00061 (Beilstein Handbook Reference); MLS001250154; DivK1c_001174; SCHEMBL196126; 2-(3-INDOLE)ETHANOL; WLN: T56 BMJ D2Q; 2-INDOLYL(3)-ETHANOL; CHEMBL226545; ISUPSL100239; ZINC3252; DTXSID2060173; BDBM92686; HMS548G02; MBBOMCVGYCRMEA-UHFFFAOYSA-; 2-(1H-Indol-3-yl)ethanol #; NSC3884; 3-(2-Hydroxy-ethyl)-1H-indole; 3-(2-Hydroxyethyl)indole, 97%; HMS2270O23; .BETA.-INDOLYLETHYL ALCOHOL; 3-.BETA.-HYDROXYETHYLINDOLE; BCP15412; 2-(3-INDOLYL)ETHYL ALCOHOL; 3-.OMEGA.-HYDROXYETHYLINDOLE; AM1052; BBL027534; s4858; STL382051; 2-(1H-indol-3-yl)ethanol;Tryptophol; AKOS002666320; AC-3286; CCG-266289; CS-W010871; HY-W010155; SB14961; CDS1_000134; NCGC00247328-01; AS-15780; SMR000686021; SY004666; DB-007578; FT-0600657; I0030; EN300-70080; C00955; T-8495; T-8500; 526T556; A829187; AE-508/40182784; Q5479351; Z1123806416; 3-(2-Hydroxyethyl)indole, Vetec(TM) reagent grade, 97%; 08DD2DF3-02E7-44DC-9714-864651873577
|
|
CAS | 526-55-6 | |
PubChem CID | 10685 | |
ChEMBL ID | CHEMBL226545 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 161.2 | ALogp: | 1.8 |
HBD: | 2 | HBA: | 1 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 36.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 12 | QED Weighted: | 0.696 |
Caco-2 Permeability: | -4.381 | MDCK Permeability: | 0.00001480 |
Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.026 |
Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.716 |
30% Bioavailability (F30%): | 0.987 |
Blood-Brain-Barrier Penetration (BBB): | 0.834 | Plasma Protein Binding (PPB): | 57.27% |
Volume Distribution (VD): | 1.96 | Fu: | 32.15% |
CYP1A2-inhibitor: | 0.97 | CYP1A2-substrate: | 0.815 |
CYP2C19-inhibitor: | 0.64 | CYP2C19-substrate: | 0.243 |
CYP2C9-inhibitor: | 0.065 | CYP2C9-substrate: | 0.921 |
CYP2D6-inhibitor: | 0.412 | CYP2D6-substrate: | 0.842 |
CYP3A4-inhibitor: | 0.142 | CYP3A4-substrate: | 0.223 |
Clearance (CL): | 9.564 | Half-life (T1/2): | 0.878 |
hERG Blockers: | 0.029 | Human Hepatotoxicity (H-HT): | 0.36 |
Drug-inuced Liver Injury (DILI): | 0.193 | AMES Toxicity: | 0.04 |
Rat Oral Acute Toxicity: | 0.432 | Maximum Recommended Daily Dose: | 0.249 |
Skin Sensitization: | 0.743 | Carcinogencity: | 0.151 |
Eye Corrosion: | 0.331 | Eye Irritation: | 0.989 |
Respiratory Toxicity: | 0.405 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000043 | 0.636 | D05EJG | 0.571 | ||||
ENC000042 | 0.628 | D0AN7B | 0.361 | ||||
ENC005609 | 0.625 | D05OIS | 0.349 | ||||
ENC005018 | 0.625 | D0S9MU | 0.329 | ||||
ENC000694 | 0.625 | D0Z6UC | 0.324 | ||||
ENC000140 | 0.571 | D0K0KH | 0.315 | ||||
ENC004706 | 0.571 | D0P9AC | 0.306 | ||||
ENC000999 | 0.565 | D0F2PO | 0.303 | ||||
ENC005757 | 0.533 | D0NG7O | 0.301 | ||||
ENC000341 | 0.523 | D02DMQ | 0.299 |